SpaceX Stock Is Back Above $150. Here’s Where The Stock Could Be by the End of 2027

SpaceX reported Q2 revenue growth of 92% year over year to $7.8B and narrowed its net loss to $541M from $1.0B, though first-half loss per share widened to $1.12 from $0.53. Consensus expects profitability to emerge, with EPS projected at $0.12 this year and $1.75 next year, but the stock's 70.8x price-to-sales and 204x forward P/E multiples leave little room for execution shortfalls. Potential upside hinges on Starship progress and a planned first AI-satellite launch by end-2027, while increased tradable share supply and project delays could constrain returns; the author caps upside at 20% through 2027 versus Wall Street's $214.57 target, implying 42% upside.

Analysis

SPCX is priced as a duration asset rather than a near-term earnings story: the critical variable is whether gross-margin improvement can compound fast enough to justify a premium multiple before incremental share supply resets the marginal buyer. A transition to modest profitability would reduce financing risk but is unlikely, by itself, to support further multiple expansion; the market will need evidence of recurring, high-margin service revenue and capital-expenditure discipline. The immediate setup is therefore asymmetric to execution: routine earnings beats may be absorbed, while any evidence of launch-cost inflation, delayed reusability milestones, or weaker cash conversion can trigger sharp de-rating.

The AI-in-space thesis is economically interesting but should be assigned low probability over the next 12-18 months. It requires not only technical launch success, but credible payload economics, radiation/thermal reliability, networking capacity, customer commitments, and a delivered cost-per-compute advantage versus terrestrial data centers. Until those inputs are disclosed, this is option value rather than forecastable revenue. NVDA is not a clean beneficiary: satellite compute could create incremental accelerator demand eventually, but only after a highly capital-intensive deployment model is validated.

Competitive spillover is more actionable. Demonstrated high-cadence, low-cost heavy-lift capability would pressure launch pricing and long-duration satellite deployment economics, creating valuation headwinds for pure-play launch peers such as RKLB while potentially expanding the addressable market for satellite-network operators such as ASTS and IRDM. Conversely, delays can improve the relative strategic value of RKLB's defense-oriented launch and spacecraft backlog. The article-derived estimates and corporate-status assumptions require reconciliation to primary filings, float data, and the lock-up calendar before sizing any SPCX position.

Key Decisions for Investors

• No outright SPCX long at current levels; require a position only after independently verifying public filings, fully diluted share count, free float, lock-up expirations, and operating cash flow. These missing data determine whether the apparent earnings inflection is investable or overwhelmed by supply.
• Set a 1-3 month short/put watch on SPCX around the first material lock-up expiry or any guidance event. Initiate only if the stock remains above its post-IPO reference range while revenue growth decelerates or free-cash-flow guidance fails to improve; cover on a verified major reusability milestone or contracted recurring-service disclosure.
• Use RKLB as the cleaner relative-value expression: long RKLB versus short SPCX only after a 15-20% SPCX relative outperformance leg and only if Starship testing remains on schedule. Thesis is that SPCX's technology premium is vulnerable to execution timing, while RKLB retains defense and spacecraft revenue diversification; exit if RKLB backlog conversion weakens or a successful high-cadence heavy-lift milestone materially changes launch-price expectations.
• Do not position in NVDA on the satellite-AI narrative. Revisit only upon disclosed payload specifications, named customers, and a credible cost-per-compute comparison with terrestrial hyperscale capacity; absent those, the relevant catalyst is years away and unlikely to affect forward estimates.